Rechercher dans la communauté
Affichage des résultats pour les étiquettes 'schering-plough'.
2 résultats trouvés
-
Québec injecte 3,3 M$ dans Schering-Plough 5 octobre 2009 | 12h15 Mathieu Lavallée Argent Québec a annoncé ce matin un investissement de 3,3 M$ dans un projet de la pharmaceutique Schering-Plough (SGP) estimé à plus de 30 M$. La contribution gouvernementale, non-remboursable, a été annoncée ce matin par le ministre du Développement économique Clément Gignac et le député de Jacques-Cartier Geoffrey Kelley. La société mondiale comptant plus de 55 employés veut moderniser et agrandir son usine de médicaments de Pointe-Claire, ce qui devrait lui permettre d’accroitre sa compétitivité et son potentiel d’exportation. Schering-Plough veut également recevoir de nouveaux mandats de production internationale. L’ensemble du projet de la société devrait maintenir les 330 emplois existants dans l’usine, en plus d’en créer une trentaine. Plus de détails suivront.
-
Schering-Plough Canada to build head office in Montreal Mar 06, 2007 06:10 PM Canadian Press MONTREAL – Drug developer Schering-Plough Canada is proceeding with plans to build a $9 million three-storey office complex that will serve as the U.S. company's new Canadian head office in Montreal's west-end. Construction is about to begin on the first phase of a 60,000-square-foot building that will be built along the Trans-Canada highway, across from rival Merck Frosst's large research complex. The Schering-Plough building could be expanded in a second phase in a couple of years, officials told The Canadian Press on Tuesday. Company president and general manager Carlos Dourado will officially unveil the project at a news conference Wednesday. The structure will occupy a portion of vacant land under a long-term lease with the property's owner, Broccolini Construction, said Guy Filiatrault, director of urban planning and business services for the town of Kirkland, Que. Town officials are finalizing a building permit for the new building, which is expected to be completed this fall, he said in an interview. Quebec Economic Minister Raymond Bachand, Native Affairs Minister Geoffrey Kelley and Kirkland Mayor John Meaney are expected to participate. Schering-Plough Canada, which employs more than 850 people across the country, is part of a New Jersey-based global company that develops prescription drugs as well as consumer and animal health products. It wasn't immediately clear how many workers will be transferred from other Schering-Plough Canada operations, including its existing headquarters in nearby Pointe Claire. Schering-Plough Canada operates a manufacturing plant in Pointe Claire, where more than 400 employees help produce 300 million tablets annually for domestic and international markets. In 2000, Schering-Plough Canada invested $25 million to modernize its manufacturing plant and expand the nearby warehouse. The project. built by Broccolini Construction, also included construction of an 86,000 square-foot, distribution centre in Kirkland. It serves the Canadian retail market and exports products to sister companies of Schering-Plough in the US, Europe and Asia. It processes 120,000 product orders annually, said the company's website. In January, Montreal-based pharma company Warnex Inc. (TSX: WNX) said it will develop new pharmacogenetic assays – used to predict a patient's response to drugs – and operate a central laboratory for several of Schering-Plough Canada's clinical studies. The Canadian company's parent, Schering-Plough Corp. (NYSE: SGP), recently reported its fourth-quarter profits surged 75 per cent as strong sales of cholesterol, arthritis and allergy medicines offset rising research and marketing spending. The company's sales include revenue from a joint venture with Merck & Co. on cholesterol drugs.
